fda compounding semaglutide crackdown news today The is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA enforcement 🚨 FDA Moves to Permanently

Judge Mark Pittman of the U.S

Approved drugs are typically dispensed through registered pharmacists

Retatrutide is still investigational and not approved by any regulator as of April 2026, so everything below is presented as clinical-trial data, not as medical guidance

According to John Lowe, MD, an internist and obesity medicine specialist at Restore Care in Ogden, Utah, several factors can impact the cash price of the weight loss medication semaglutide, such as: The dosage and frequency of injections The pharmacy or retailer Where you live Manufacturer discounts or patient assistance programs According to the drugs manufacturer, Novo Nordisk, it costs $998 for 1 3 ml of 2 mg/ml auto-injector pen, which typically lasts one month